Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1986 Mar;57(3):1139–1144. doi: 10.1128/jvi.57.3.1139-1144.1986

Effects of cyclosporin A on humoral immune response and resistance against vesicular stomatitis virus in mice.

S Charan, A W Huegin, A Cerny, H Hengartner, R M Zinkernagel
PMCID: PMC252848  PMID: 3005615

Abstract

The effect of cyclosporin A (CS-A) on the antiviral humoral response was studied by using vesicular stomatitis virus (VSV); VSV provided the opportunity to simultaneously assess both T-independent and T-dependent antibody responses. The T-independent anti-VSV immunoglobulin M (IgM) response was virtually unaffected, whereas the T-dependent primary anti-VSV IgG response was suppressed by CS-A; in contrast, the secondary IgG response was highly resistant to CS-A. Moreover, once the switch from IgM to IgG had occurred, the primary response also became refractory to suppression by CS-A. We concluded that the effect of CS-A on the primary anti-VSV antibody response was mediated via impairment of a T-dependent mechanism; in contrast, memory T cells or memory B cells or both were quite resistant to the suppressive effects of CS-A. CS-A treatment rendered mice highly susceptible to VSV infection; under CS-A treatment, mortality was 100% after infection via footpads, whereas immunocompetent mice survived. Since CS-A does not impair induction of early T-independent anti-VSV IgM neutralizing antibodies, this high mortality in CS-A treated mice illustrates the crucial role of CS-A-sensitive cells in resistance against VSV.

Full text

PDF
1139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abb J., Abb H., Deinhardt F. Effect of cyclosporin A on the production of interferon by human peripheral blood leukocytes in vitro. Antiviral Res. 1982 Dec;2(6):361–367. doi: 10.1016/0166-3542(82)90006-7. [DOI] [PubMed] [Google Scholar]
  2. Armerding D., Scriba M., Hren A., Rossiter H. Modulation by cyclosporin A of murine natural resistance against herpes simplex virus infection. I. Interference with the susceptibility to herpes simplex virus infection. Antiviral Res. 1982 May;2(1-2):3–11. doi: 10.1016/0166-3542(82)90022-5. [DOI] [PubMed] [Google Scholar]
  3. Armerding D. Selective induction of immunological tolerance in antiviral T killer cells of inbred mice after treatment with cyclosporin A. Infect Immun. 1981 Jun;32(3):1164–1175. doi: 10.1128/iai.32.3.1164-1175.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bird A. G., McLachlan S. M., Britton S. Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature. 1981 Jan 22;289(5795):300–301. doi: 10.1038/289300a0. [DOI] [PubMed] [Google Scholar]
  5. Bolton C., Allsopp G., Cuzner M. L. The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat. Clin Exp Immunol. 1982 Jan;47(1):127–132. [PMC free article] [PubMed] [Google Scholar]
  6. Borel J. F., Feurer C., Magnée C., Stähelin H. Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology. 1977 Jun;32(6):1017–1025. [PMC free article] [PubMed] [Google Scholar]
  7. Britton S., Palacios R. Cyclosporin A--usefulness, risks and mechanism of action. Immunol Rev. 1982;65:5–22. doi: 10.1111/j.1600-065x.1982.tb00425.x. [DOI] [PubMed] [Google Scholar]
  8. Bruno-Lobo M., Peralta P. H., Bruno-Lobo G. G., de Paola D. Pathogenesis of vesicular stomatitis virus New Jersey infection in the adult hamster and mouse. An Microbiol (Rio J) 1968;15:69–80. [PubMed] [Google Scholar]
  9. Bruno-Lobo M., Peralta P. H., Bruno-Lobo G. G., de Paola D. Pathogenesis of vesicular stomatitis virus infection in the infant hamster and mouse. An Microbiol (Rio J) 1968;15:53–68. [PubMed] [Google Scholar]
  10. Bunjes D., Hardt C., Röllinghoff M., Wagner H. Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol. 1981 Aug;11(8):657–661. doi: 10.1002/eji.1830110812. [DOI] [PubMed] [Google Scholar]
  11. Burns W., Billups L. C., Notkins A. L. Thymus dependence of viral antigens. Nature. 1975 Aug 21;256(5519):654–656. doi: 10.1038/256654a0. [DOI] [PubMed] [Google Scholar]
  12. Goodman-Snitkoff G. W., McSharry J. J. Activation of mouse lymphocytes by vesicular stomatitis virus. J Virol. 1980 Sep;35(3):757–765. doi: 10.1128/jvi.35.3.757-765.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Granelli-Piperno A., Inaba K., Steinman R. M. Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A. J Exp Med. 1984 Dec 1;160(6):1792–1802. doi: 10.1084/jem.160.6.1792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Huegin A. W., Cerny A., Hengartner H., Zinkernagel R. M. Suppression by cyclosporin A of murine T-cell-mediated immunity against viruses in vivo and in vitro. Cell Immunol. 1985 Feb;90(2):464–473. doi: 10.1016/0008-8749(85)90211-4. [DOI] [PubMed] [Google Scholar]
  15. Ihle J. N., Rebar L., Keller J., Lee J. C., Hapel A. J. Interleukin 3: possible roles in the regulation of lymphocyte differentiation and growth. Immunol Rev. 1982;63:5–32. doi: 10.1111/j.1600-065x.1982.tb00409.x. [DOI] [PubMed] [Google Scholar]
  16. Krönke M., Leonard W. J., Depper J. M., Arya S. K., Wong-Staal F., Gallo R. C., Waldmann T. A., Greene W. C. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A. 1984 Aug;81(16):5214–5218. doi: 10.1073/pnas.81.16.5214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kunkl A., Klaus G. G. Selective effects of cyclosporin A on functional B cell subsets in the mouse. J Immunol. 1980 Dec;125(6):2526–2531. [PubMed] [Google Scholar]
  18. Like A. A., Dirodi V., Thomas S., Guberski D. L., Rossini A. A. Prevention of diabetes mellitus in the BB/W rat with Cyclosporin-A. Am J Pathol. 1984 Oct;117(1):92–97. [PMC free article] [PubMed] [Google Scholar]
  19. Nussenblatt R. B., Palestine A. G., Rook A. H., Scher I., Wacker W. B., Gery I. Treatment of intraocular inflammatory disease with cyclosporin A. Lancet. 1983 Jul 30;2(8344):235–238. doi: 10.1016/s0140-6736(83)90230-1. [DOI] [PubMed] [Google Scholar]
  20. Palacios R., Martinez-Maza O., De Ley M. Production of human immune interferon (Hu IFN-gamma) studied at the single cell level. Origin, evidence for spontaneous secretion and effect of cyclosporin A. Eur J Immunol. 1983 Mar;13(3):221–225. doi: 10.1002/eji.1830130308. [DOI] [PubMed] [Google Scholar]
  21. Parker D., Drössler K., Turk J. L. Kinetics of the effect of a single dose of cyclosporin-A on antibody and cell mediated immune responses in the guinea pig. Int J Immunopharmacol. 1984;6(1):67–74. doi: 10.1016/0192-0561(84)90037-7. [DOI] [PubMed] [Google Scholar]
  22. Rosenthal K. L., Zinkernagel R. M. Inability of mice to generate cytotoxic T lymphocytes to vesicular stomatitis virus restricted to H-2Kk or H-2Dk. J Immunol. 1981 Feb;126(2):446–451. [PubMed] [Google Scholar]
  23. Rothman J. E., Fries E. Transport of newly synthesized vesicular stomatitis viral glycoprotein to purified Golgi membranes. J Cell Biol. 1981 Apr;89(1):162–168. doi: 10.1083/jcb.89.1.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schiltknecht E., Ada G. L. In vivo effects of cyclosporine on influenza A virus-infected mice. Cell Immunol. 1985 Mar;91(1):227–239. doi: 10.1016/0008-8749(85)90046-2. [DOI] [PubMed] [Google Scholar]
  25. Scott D. W., Gershon R. K. Determination of total and merecaptothanol-resistant antibody in the same serum sample. Clin Exp Immunol. 1970 Feb;6(2):313–316. [PMC free article] [PubMed] [Google Scholar]
  26. Shevach E. M. The effects of cyclosporin A on the immune system. Annu Rev Immunol. 1985;3:397–423. doi: 10.1146/annurev.iy.03.040185.002145. [DOI] [PubMed] [Google Scholar]
  27. Shidani B., Colle J. H., Motta I., Truffa-Bachi P. Effect of cyclosporin A on the induction and activation of B memory cells by thymus-independent antigens in mice. Eur J Immunol. 1983 May;13(5):359–363. doi: 10.1002/eji.1830130503. [DOI] [PubMed] [Google Scholar]
  28. Smith J. S. Mouse model for abortive rabies infection of the central nervous system. Infect Immun. 1981 Jan;31(1):297–308. doi: 10.1128/iai.31.1.297-308.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Thomson A. W. Immunobiology of cyclosporin A--a review. Aust J Exp Biol Med Sci. 1983 Apr;61(Pt 2):147–172. doi: 10.1038/icb.1983.14. [DOI] [PubMed] [Google Scholar]
  30. Thomson A. W., Whiting P. H., Simpson J. G. Cyclosporine: immunology, toxicity and pharmacology in experimental animals. Agents Actions. 1984 Oct;15(3-4):306–327. doi: 10.1007/BF01972366. [DOI] [PubMed] [Google Scholar]
  31. Tosato G., Pike S. E., Koski I. R., Blaese R. M. Selective inhibition of immunoregulatory cell functions by cyclosporin A. J Immunol. 1982 May;128(5):1986–1991. [PubMed] [Google Scholar]
  32. Weil C. Cyclosporin a: review of results in organ and bone-marrow transplantation in man. Med Res Rev. 1984 Apr-Jun;4(2):221–265. doi: 10.1002/med.2610040205. [DOI] [PubMed] [Google Scholar]
  33. White D. J., Calne R. Y. The use of Cyclosporin A immunosuppression in organ grafting. Immunol Rev. 1982;65:115–131. doi: 10.1111/j.1600-065x.1982.tb00430.x. [DOI] [PubMed] [Google Scholar]
  34. Zubler R. H., Lowenthal J. W., Erard F., Hashimoto N., Devos R., MacDonald H. R. Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. J Exp Med. 1984 Oct 1;160(4):1170–1183. doi: 10.1084/jem.160.4.1170. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES